Followers | 1610 |
Posts | 118781 |
Boards Moderated | 20 |
Alias Born | 08/20/2006 |
Tuesday, August 10, 2021 11:09:55 PM
Revenues were US$15.2 million, an increase of 186.8% from $5.3 million in the second quarter of 2020
Gross profit was $7.9 million, an increase of 192.6% from $2.7 million in the second quarter of 2020.
Gross margin was 51.9%, compared with 50.7% in the second quarter of 2020.
Net income was $5.1 million, compared to $2.0 million in the second quarter of 2020.
Total volume shipped was 711,548 units, an increase of 145.6% from 289,668 units in the second quarter of 2020.
Cash flow from operations was $11.1 million, compared to $5.6 million in the six months ended June 30, 2020.
Cash as of the end of the second quarter of 2021 was $52.6 million, compared to $23.0 million as of December 31, 2020.
Basic and diluted EPS were $0.2, compared with $0.1 in the same period of 2020.
Recent WETH News
- Wetouch Technology Inc. Unveils Cutting-Edge Second-Generation Touchscreen Products and Receives US $15M in Orders • PR Newswire (US) • 05/06/2024 01:45:00 PM
- Wetouch Technology Inc. Announces $56.3M USD Revenue Guidance for FY 2024, Reflecting 41% Growth Over FY 2023 • PR Newswire (US) • 04/22/2024 02:00:00 PM
- Wetouch Technology Inc. Preannounce Earnings for Fiscal Year 2023 • PR Newswire (US) • 04/01/2024 02:21:00 PM
- Wetouch Announces Strategic Collaboration with IDEC Corporation, Elevating Presence in Japanese Touch Display Market • PR Newswire (US) • 03/18/2024 01:17:00 PM
- WestPark Capital Announces Closing of $10.8 Million Public Offering of Common Stock for Wetouch Technology Inc (Nasdaq: WETH ) • Business Wire • 02/28/2024 02:00:00 PM
- Wetouch Technology Inc. Announces Closing of $10.8 Million Public Offering of Common Stock • GlobeNewswire Inc. • 02/23/2024 09:00:00 PM
- Wetouch Technology Inc. Announces Pricing of $10.8 Million Public Offering of Common Stock and Concurrent Uplisting to the Nasdaq Capital Market • GlobeNewswire Inc. • 02/21/2024 02:45:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM